Home | Business News | Browse by Publication | P | Pharma Marketletter

Alchemia licenses VAST tech to SDP.

Publication: Pharma Marketletter
Publication Date: 23-MAR-09 		Format: Online
Delivery: Immediate Online Access
Full Article Title: Alchemia licenses VAST tech to SDP.(SDP Technology)(Brief article)

Article Excerpt
Australian drug developer Alchemia has entered into a drug-discovery agreement with Melbourne-based SDP Technology to develop anticancer drugs targeting the enzyme sphingosine kinase 1 (SK1) using Alchemia's VAST chemistry.

Under the terms of the deal, SDP will have rights to the structural data from the initial screen and to...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
AM-Pharma gets 5M-euro govt loan.(SenterNovem)(Brief article), March 23, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.